Showing results (81-90 of 16,792) with videos related to
Sort By:
Pageof 1,680
British Journal of Haematology|May 1, 1985
Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysisG Tricot, R Vlietinck, M A Boogaerts, et al.British Journal of Haematology|July 19, 2022
Quality of life in mothers and fathers of children treated for acute lymphoblastic leukaemia in Sweden, Finland and DenmarkNina Mogensen, Ella Saaranen, Erik Olsson, et al.British Journal of Haematology|July 28, 2022
Time from diagnosis to treatment is associated with survival in patients with acute myeloid leukaemia: An analysis of 55 985 patients from the National Cancer DatabaseAseel Alsouqi, Scott D Rothenberger, Michael Boyiadzis, et al.British Journal of Haematology|February 1, 1979
Two populations of factor VIII-related antigen in a family with von Willebrand's diseaseH Armitage, C R RizzaBritish Journal of Haematology|July 20, 2022
A computational model for prediction of ferritin and haemoglobin levels in blood donorsYared Paalvast, Sara Moazzen, Maike Sweegers, et al.British Journal of Haematology|October 20, 2010
Molecular characterization of paediatric idiopathic hypereosinophiliaMaria Cristina Rapanotti, Roberta Caruso, Emanuele Ammatuna, et al.British Journal of Haematology|October 20, 2010
Desensitization to hydroxycarbamide following long-term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patientsPaolo Rigano, Alice Pecoraro, Roberta Calzolari, et al.British Journal of Haematology|October 1, 1990
Philadelphia chromosome positive B-cell type malignant lymphoma expressing an aberrant 190 kDa bcr-abl proteinK Mitani, Y Sato, A Tojo, et al.British Journal of Haematology|October 1, 1990
Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpuraA Juliá, C Araguás, J Rosselló, et al.British Journal of Haematology|October 1, 1990
Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). II. Clinical observationsA N Bartlett, A V Hoffbrand, G J KontoghiorghesPageof 1,680